These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 32891735

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms severity score: A useful tool for assessing disease severity and predicting fatal cytomegalovirus disease.
    Mizukawa Y, Hirahara K, Kano Y, Shiohara T.
    J Am Acad Dermatol; 2019 Mar; 80(3):670-678.e2. PubMed ID: 30240780
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Severe graft-versus-host disease-like enterocolitis accompanied with cytomegalovirus-reactivation in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms.
    Takamiyagi S, Iriki H, Asahina Y, Furuichi Y, Funakoshi T, Ichikawa M, Mikami Y, Okita H, Sakiyama T, Inazumi T, Amagai M, Takahashi H.
    J Dermatol; 2022 Aug; 49(8):796-799. PubMed ID: 35502510
    [Abstract] [Full Text] [Related]

  • 5. Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis.
    Hama N, Abe R, Gibson A, Phillips EJ.
    J Allergy Clin Immunol Pract; 2022 May; 10(5):1155-1167.e5. PubMed ID: 35176506
    [Abstract] [Full Text] [Related]

  • 6. Current Perspective Regarding the Immunopathogenesis of Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Miyagawa F, Asada H.
    Int J Mol Sci; 2021 Feb 21; 22(4):. PubMed ID: 33670052
    [Abstract] [Full Text] [Related]

  • 7. Drug-induced hypersensitivity syndrome (DiHS)/drug reaction with eosinophilia and systemic symptoms (DRESS): An update in 2019.
    Shiohara T, Mizukawa Y.
    Allergol Int; 2019 Jul 21; 68(3):301-308. PubMed ID: 31000444
    [Abstract] [Full Text] [Related]

  • 8. The dynamics of herpesvirus reactivations during and after severe drug eruptions: their relation to the clinical phenotype and therapeutic outcome.
    Ishida T, Kano Y, Mizukawa Y, Shiohara T.
    Allergy; 2014 Jun 21; 69(6):798-805. PubMed ID: 24749495
    [Abstract] [Full Text] [Related]

  • 9. Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).
    Kano Y, Tohyama M, Aihara M, Matsukura S, Watanabe H, Sueki H, Iijima M, Morita E, Niihara H, Asada H, Kabashima K, Azukizawa H, Hashizume H, Nagao K, Takahashi H, Abe R, Sotozono C, Kurosawa M, Aoyama Y, Chu CY, Chung WH, Shiohara T.
    J Dermatol; 2015 Mar 21; 42(3):276-82. PubMed ID: 25623158
    [Abstract] [Full Text] [Related]

  • 10. Cytomegalovirus reactivation in a general, nonimmunosuppressed intensive care unit population: incidence, risk factors, associations with organ dysfunction, and inflammatory biomarkers.
    Frantzeskaki FG, Karampi ES, Kottaridi C, Alepaki M, Routsi C, Tzanela M, Vassiliadi DA, Douka E, Tsaousi S, Gennimata V, Ilias I, Nikitas N, Armaganidis A, Karakitsos P, Papaevangelou V, Dimopoulou I.
    J Crit Care; 2015 Apr 21; 30(2):276-81. PubMed ID: 25457114
    [Abstract] [Full Text] [Related]

  • 11. Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?
    Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V.
    Br J Dermatol; 2014 Oct 21; 171(4):895-8. PubMed ID: 24773172
    [Abstract] [Full Text] [Related]

  • 12. Human herpes virus reactivations and dynamic cytokine profiles in patients with cutaneous adverse drug reactions --a prospective comparative study.
    Chen YC, Chiang HH, Cho YT, Chang CY, Chen KL, Yang CW, Lee YH, Chu CY.
    Allergy; 2015 May 21; 70(5):568-75. PubMed ID: 25727950
    [Abstract] [Full Text] [Related]

  • 13. Occupational trichloroethylene hypersensitivity syndrome: human herpesvirus 6 reactivation and rash phenotypes.
    Kamijima M, Wang H, Yamanoshita O, Ito Y, Xia L, Yanagiba Y, Chen C, Okamura A, Huang Z, Qiu X, Song X, Cai T, Liu L, Ge Y, Deng Y, Naito H, Yoshikawa T, Tohyama M, Li L, Huang H, Nakajima T.
    J Dermatol Sci; 2013 Dec 21; 72(3):218-24. PubMed ID: 23928230
    [Abstract] [Full Text] [Related]

  • 14. Longitudinal analysis of antibody profiles against plakins in severe drug eruptions: emphasis on correlation with tissue damage in drug-induced hypersensitivity syndrome and drug reaction with eosinophilia and systemic symptoms.
    Takehara A, Aoyama Y, Kurosawa M, Shirafuji Y, Umemura H, Kamiya K, Ushigome Y, Kano Y, Shiohara T, Iwatsuki K.
    Br J Dermatol; 2016 Nov 21; 175(5):944-952. PubMed ID: 27087170
    [Abstract] [Full Text] [Related]

  • 15. Serum Soluble OX40 as a Diagnostic and Prognostic Biomarker for Drug-Induced Hypersensitivity Syndrome/Drug Reaction with Eosinophilia and Systemic Symptoms.
    Mitsui Y, Shinkuma S, Nakamura-Nishimura Y, Ommori R, Ogawa K, Miyagawa F, Mori Y, Tohyama M, Asada H.
    J Allergy Clin Immunol Pract; 2022 Feb 21; 10(2):558-565.e4. PubMed ID: 34757063
    [Abstract] [Full Text] [Related]

  • 16. Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome.
    Seishima M, Yamanaka S, Fujisawa T, Tohyama M, Hashimoto K.
    Br J Dermatol; 2006 Aug 21; 155(2):344-9. PubMed ID: 16882173
    [Abstract] [Full Text] [Related]

  • 17. Reactivation of Human Herpes Virus-6 in the Renal Tissue of a Patient with Drug-induced Hypersensitivity Syndrome/Drug Rash with Eosinophilia and Systemic Symptoms (DIHS/DRESS).
    Hagiya H, Iwamuro M, Tanaka T, Hasegawa K, Hanayama Y, Kimura M, Otsuka F.
    Intern Med; 2016 Aug 21; 55(13):1769-74. PubMed ID: 27374681
    [Abstract] [Full Text] [Related]

  • 18. Effect of cytomegalovirus reactivation on the time course of systemic host response biomarkers in previously immunocompetent critically ill patients with sepsis: a matched cohort study.
    van de Groep K, Nierkens S, Cremer OL, Peelen LM, Klein Klouwenberg PMC, Schultz MJ, Hack CE, van der Poll T, Bonten MJM, Ong DSY, MARS consortium.
    Crit Care; 2018 Dec 18; 22(1):348. PubMed ID: 30563551
    [Abstract] [Full Text] [Related]

  • 19. Monocytes are involved in the balance between regulatory T cells and Th17 cells in severe drug eruptions.
    Ushigome Y, Mizukawa Y, Kimishima M, Yamazaki Y, Takahashi R, Kano Y, Shiohara T.
    Clin Exp Allergy; 2018 Nov 18; 48(11):1453-1463. PubMed ID: 30112775
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.